BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 21733551)

  • 1. Senescence in intraductal papillary mucinous neoplasm of the pancreas.
    Miyasaka Y; Nagai E; Ohuchida K; Fujita H; Nakata K; Hayashi A; Mizumoto K; Tsuneyoshi M; Tanaka M
    Hum Pathol; 2011 Dec; 42(12):2010-7. PubMed ID: 21733551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation.
    Hayashi A; Aishima S; Miyasaka Y; Nakata K; Morimatsu K; Oda Y; Nagai E; Oda Y; Tanaka M; Tsuneyoshi M
    Hum Pathol; 2010 Nov; 41(11):1507-15. PubMed ID: 20656320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
    Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
    Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100P is a novel marker to identify intraductal papillary mucinous neoplasms.
    Nakata K; Nagai E; Ohuchida K; Hayashi A; Miyasaka Y; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
    Hum Pathol; 2010 Jun; 41(6):824-31. PubMed ID: 20153506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal papillary mucinous neoplasm.
    Shi C; Hruban RH
    Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
    Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
    Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
    Sasaki S; Yamamoto H; Kaneto H; Ozeki I; Adachi Y; Takagi H; Matsumoto T; Itoh H; Nagakawa T; Miyakawa H; Muraoka S; Fujinaga A; Suga T; Satoh M; Itoh F; Endo T; Imai K
    Oncol Rep; 2003; 10(1):21-5. PubMed ID: 12469138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
    Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
    Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas.
    Kloek JJ; van der Gaag NA; Erdogan D; Rauws EA; Busch OR; Gouma DJ; ten Kate FJ; van Gulik TM
    Hum Pathol; 2011 Jun; 42(6):824-32. PubMed ID: 21292296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.
    Furukawa T; Fujisaki R; Yoshida Y; Kanai N; Sunamura M; Abe T; Takeda K; Matsuno S; Horii A
    Mod Pathol; 2005 Aug; 18(8):1034-42. PubMed ID: 15832194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
    Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
    Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical characteristics and malignant progression of hepatic cystic neoplasms in comparison with pancreatic counterparts.
    Matsubara T; Sato Y; Sasaki M; Harada K; Nomoto K; Tsuneyama K; Nakamura K; Gabata T; Matsui O; Nakanuma Y
    Hum Pathol; 2012 Dec; 43(12):2177-86. PubMed ID: 22705005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas.
    Miyasaka Y; Nagai E; Yamaguchi H; Fujii K; Inoue T; Ohuchida K; Yamada T; Mizumoto K; Tanaka M; Tsuneyoshi M
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4371-7. PubMed ID: 17671118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal papillary-mucinous tumors of the pancreas.
    Kubosawa H; Uehara T; Watanabe Y; Urashima T; Matsubara H; Asano T; Ochiai T
    Hepatogastroenterology; 2004; 51(59):1489-94. PubMed ID: 15362784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
    Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS
    Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm?
    Klöppel G; Kosmahl M
    J Hepatol; 2006 Feb; 44(2):249-50. PubMed ID: 16360969
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas.
    Sanada Y; Kunita S; Yoshida K
    Oncol Rep; 2008 Jun; 19(6):1435-43. PubMed ID: 18497948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma.
    Kelly PJ; Shinagare S; Sainani N; Hong X; Ferrone C; Yilmaz O; Fernández-del Castillo C; Lauwers GY; Deshpande V
    Am J Surg Pathol; 2012 May; 36(5):696-701. PubMed ID: 22367300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
    Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
    J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of the most severely dysplastic/invasive lesions and mucin phenotypes in intraductal papillary mucinous neoplasm of the pancreas.
    Karasaki H; Mizukami Y; Tokusashi Y; Koizumi K; Ishizaki A; Imai K; Yoshikawa D; Kino S; Sasajima J; Tanno S; Matsumoto K; Miyokawa N; Kono T; Kohgo Y; Furukawa H
    Pancreas; 2011 May; 40(4):588-94. PubMed ID: 21441843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.